Principal Financial Group Inc. Reduces Stock Position in Amedisys, Inc. (NASDAQ:AMED)

Principal Financial Group Inc. trimmed its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 30.5% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 75,526 shares of the health services provider's stock after selling 33,149 shares during the quarter. Principal Financial Group Inc. owned 0.23% of Amedisys worth $7,289,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Innealta Capital LLC acquired a new position in Amedisys in the 2nd quarter valued at $64,000. Covestor Ltd grew its holdings in Amedisys by 134.2% in the 1st quarter. Covestor Ltd now owns 780 shares of the health services provider's stock valued at $72,000 after buying an additional 447 shares in the last quarter. Signaturefd LLC grew its holdings in Amedisys by 88.2% in the 2nd quarter. Signaturefd LLC now owns 1,131 shares of the health services provider's stock valued at $104,000 after buying an additional 530 shares in the last quarter. CWM LLC grew its holdings in shares of Amedisys by 14.5% during the 3rd quarter. CWM LLC now owns 2,190 shares of the health services provider's stock worth $211,000 after purchasing an additional 277 shares in the last quarter. Finally, GAM Holding AG acquired a new stake in shares of Amedisys during the 2nd quarter worth $275,000. 94.36% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on AMED. Deutsche Bank Aktiengesellschaft lowered shares of Amedisys from a "buy" rating to a "hold" rating and set a $101.00 price target on the stock. in a report on Monday, July 29th. Cantor Fitzgerald reissued a "neutral" rating and issued a $101.00 price objective on shares of Amedisys in a research note on Thursday, July 25th. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Amedisys currently has an average rating of "Hold" and an average price target of $100.67.

Amedisys Stock Down 0.1 %

AMED traded down $0.05 during midday trading on Wednesday, reaching $89.95. 96,750 shares of the company were exchanged, compared to its average volume of 358,891. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. The company's fifty day moving average price is $95.73 and its 200 day moving average price is $95.82. The company has a market cap of $2.95 billion, a price-to-earnings ratio of 35.71, a price-to-earnings-growth ratio of 1.87 and a beta of 0.78. Amedisys, Inc. has a one year low of $88.81 and a one year high of $98.95.

Amedisys (NASDAQ:AMED - Get Free Report) last released its earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.19). The business had revenue of $587.67 million during the quarter, compared to the consensus estimate of $586.75 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The business's revenue was up 5.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.98 earnings per share. As a group, analysts expect that Amedisys, Inc. will post 4.6 EPS for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.